Skip to main content

Table 3 Clinical Outcomes

From: The clinical relevance of luteal phase progesterone support in true natural cycle cryopreserved blastocyst stage embryo transfers: a retrospective cohort study

 

Progesterone Supplementation (n = 149)

No Progesterone Supplementation (n = 80)

Unadjusted Statistics (p value and risk ratio*)

Age-Adjusted Statistics

Positive hCG

93 (62.4%)

46 (57.5%)

0.5039

1.08 (0.86, 1.37)

0.5965

1.07 (0.84, 1.35)

Clinical pregnancy

75 (50.3%)

38 (47.5%)

0.6592

1.07 (0.80, 1.42)

0.7483

1.05 (0.79,1.39)

Miscarriage / Abortion

8 (5.4%)

2 (2.5%)

0.2918

2.21 (0.51, 9.68)

0.2622

2.33 (0.53, 10.24)

Ectopic pregnancy

0 (0.0%)

1 (1.3%)

0.3493

(no further modeling)

Multifetal gestation

11 (7.4%)

3 (3.8%)

0.2835

1.98 (0.57, 6.95)

0.3166

1.87 (0.55, 6.36)

Ongoing Pregnancy

73 (49.0%)

38 (47.5%)

0.7871

1.04 (0.78, 1.39)

0.8738

1.01 (0.76, 1.34)

  1. Values are total number (%) or p-value and age-adjusted risk ratio with 95% CIs